Toronto Dominion Bank raised its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 11.6% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 202,571 shares of the medical equipment provider's stock after buying an additional 21,079 shares during the period. Toronto Dominion Bank owned about 0.06% of Intuitive Surgical worth $105,734,000 at the end of the most recent reporting period.
Several other institutional investors have also added to or reduced their stakes in ISRG. Brighton Jones LLC grew its position in shares of Intuitive Surgical by 24.9% in the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock worth $1,916,000 after buying an additional 731 shares during the last quarter. Cornerstone Wealth Management LLC grew its position in shares of Intuitive Surgical by 4.8% in the 4th quarter. Cornerstone Wealth Management LLC now owns 550 shares of the medical equipment provider's stock worth $287,000 after buying an additional 25 shares during the last quarter. Flagship Harbor Advisors LLC grew its position in shares of Intuitive Surgical by 3.2% in the 4th quarter. Flagship Harbor Advisors LLC now owns 3,165 shares of the medical equipment provider's stock worth $1,652,000 after buying an additional 97 shares during the last quarter. Jacksonville Wealth Management LLC bought a new stake in shares of Intuitive Surgical in the 4th quarter worth approximately $2,108,000. Finally, AlphaMark Advisors LLC grew its position in shares of Intuitive Surgical by 300.0% in the 4th quarter. AlphaMark Advisors LLC now owns 96 shares of the medical equipment provider's stock worth $50,000 after buying an additional 72 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.
Analyst Upgrades and Downgrades
A number of brokerages have recently weighed in on ISRG. Evercore ISI cut their price objective on Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating on the stock in a research report on Wednesday, April 23rd. Royal Bank of Canada lowered their target price on Intuitive Surgical from $630.00 to $605.00 and set an "outperform" rating for the company in a research note on Wednesday, April 23rd. Barclays dropped their price target on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research report on Thursday, April 24th. Robert W. Baird decreased their price objective on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Finally, Truist Financial lowered their price objective on Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a research report on Wednesday, April 23rd. Five equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $596.05.
Get Our Latest Analysis on Intuitive Surgical
Insider Buying and Selling
In related news, EVP Brian Edward Miller sold 8,900 shares of the company's stock in a transaction on Tuesday, March 11th. The stock was sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the completion of the sale, the executive vice president now owns 5,758 shares in the company, valued at approximately $2,793,033.06. This represents a 60.72% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Robert Desantis sold 11,545 shares of the firm's stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the transaction, the executive vice president now directly owns 5,224 shares in the company, valued at $2,607,925.28. The trade was a 68.85% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 32,700 shares of company stock worth $16,865,621. 0.70% of the stock is owned by corporate insiders.
Intuitive Surgical Trading Up 0.4%
NASDAQ:ISRG traded up $2.22 during trading hours on Wednesday, reaching $552.41. 1,009,584 shares of the company traded hands, compared to its average volume of 1,645,419. The business's 50-day moving average price is $513.67 and its two-hundred day moving average price is $538.20. The stock has a market capitalization of $197.99 billion, a P/E ratio of 86.18, a P/E/G ratio of 5.85 and a beta of 1.70. Intuitive Surgical, Inc. has a 1 year low of $396.15 and a 1 year high of $616.00.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The business had revenue of $2.25 billion during the quarter, compared to analysts' expectations of $2.19 billion. During the same quarter in the previous year, the business earned $1.50 earnings per share. As a group, equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.
Intuitive Surgical Company Profile
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Further Reading

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.